The development of hybridization assays based on an apoaequorin-encoding DNA label is reported. The constructed label contains the T7 RNA polymerase promoter, the apoaequorin coding sequence and a downstream (dA/dT) 30 . In the captured target configuration, biotinylated target DNA (233 bp) was captured on streptavidin-coated microtiter wells and hybridized to a poly(dT)-tailed detection probe. In the sandwich-type assay, the target DNA was hybridized simultaneously with an immobilized capture probe (through biotin/streptavidin) and a poly(dT)-tailed detection probe. In both configurations, the hybrids were reacted with poly(dA)-tailed apoaequorin DNA. The DNA label was subjected to in vitro transcription/ translation to produce apoaequorin, which was converted to active aequorin in the reaction mixture. Generated aequorin was determined by its characteristic Ca 2+ -triggered bioluminescence. Each DNA label was estimated to produce 156 aequorin molecules. As low as 0.25 and 0.5 amol of target DNA were detected with the sandwich-type and captured target hybridization assays, respectively, with a linear range spanning four orders of magnitude. In comparison, captured target hybridization assays using photoprotein aequorin or firefly luciferase-encoding DNA labels were able to detect 25 and 20.5 amol of target DNA, respectively. The dramatic improvement in sensitivity observed with the proposed systems is attributed to amplification introduced by in vitro expression of apoaequorin DNA into multiple active aequorin molecules.
INTRODUCTION
The nucleic acid hybridization assay has become a fundamental analytical technique with a wide spectrum of applications including analysis of point mutations, deletions or insertions associated with disease, detection/determination of viral or bacterial nucleic acids in clinical and environmental samples and DNA fingerprinting. Current research efforts in the area of hybridization assays are focused on two directions: (i) the improvement of sensitivity while avoiding the use of radioisotopes; and (ii) the facilitation of automation and high throughput analysis.
Sensitivity is determined mainly by the detectability of the molecules used for probe labeling. Hybridization assays based on fluorescent (e.g. fluorescein and lanthanide chelates) and chemiluminescent (e.g. acridinium esters) labels have been developed. Assay sensitivity can be enhanced through signal amplification. Enzymes (such as alkaline phosphatase and horseradish peroxidase) are the most widely used nonradioactive labels because they provide signal amplification through the high turnover of substrate to detectable products (1) . Further signal amplification can be introduced either by attaching multiple enzyme molecules per probe, through the branched chain DNA system (2), or by using enzyme-coding DNA fragments as labels which, upon expression, generate several enzyme molecules in solution (3) .
The Ca 2+ -dependent photoprotein aequorin is a complex of the apoprotein apoaequorin (a single polypeptide chain of 189 amino acids), coelenterazine and oxygen, which is attached to coelenterazine as a peroxide. Apoaequorin has three Ca 2+ -binding sites. When Ca 2+ binds to aequorin, it induces a conformational change in the protein, which causes oxidation of coelenterazine by the bound oxygen to produce coelenteramide, CO 2 and light (λ max 470 nm). The light emitter is the excited state of coelenteramide bound to apoaequorin (4) . A remarkable property of apoaequorin is its ability to form fully functional aequorin when incubated with coelenterazine in the presence of O 2 in the appropriate buffer, containing dithiothreitol (DTT) or 2-mercaptoethanol (5). This ability is exploited in the present work. The apoaequorin cDNA has been cloned and sequenced (6) and the preparation of recombinant aequorin has been reported (7) .
Aequorin has been used extensively for the determination of intracellular Ca 2+ (in the cytosol and subcellular compartments) (8) . Aequorin is also an excellent reporter molecule since it can be detected at the attomole level in the presence of excess Ca 2+ (9) . This has led to the use of recombinant aequorin as a label in immunoassays (10) . Biotinylated aequorin has been effective for the detection of proteins and nucleic acids on western or Southern blots (11) . Conjugates of recombinant aequorin with streptavidin or anti-digoxigenin antibody have been used in hybridization assays and *To whom correspondence should be addressed. Tel: +1 519 253 4232; Fax: +1 519 973 7098; Email: tkc@uwindsor.ca e25 Nucleic Acids Research, 1999, Vol. 27, No. 19 ii quantitative PCR (12, 13) . Fusion proteins consisting of aequorin and IgG heavy chain were also prepared for use in immunoassays (14) .
In the present work, we developed a signal amplification system based on a DNA label encoding apoaequorin. After completion of the hybridization reaction in microtiter wells, the apoaequorin DNA (which is bound to the hybrids) is subjected to in vitro one-step transcription and translation, thus generating multiple apoaequorin molecules in solution. The apoaequorin is converted into fully active aequorin in the transcription/translation mixture. The aequorin produced is determined by adding a Ca 2+ -containing solution and measuring the characteristic bioluminescence. First we engineered expressible DNA labels encoding apoaequorin and studied the expression of apoaequorin and the formation of active aequorin. Then, we investigated the relationship between the amount of DNA label and the analytical signal (bioluminescence) obtained after expression. Subsequently, two hybridization assay configurations were developed. Finally, we compared the proposed assays with hybridization assays in which the photoprotein aequorin was used as a label as well as with assays that use a DNA label encoding firefly luciferase.
MATERIALS AND METHODS

Instrumentation
A 48-well DNA Thermal Cycler from Perkin-Elmer Cetus (Norwalk, CT) was used for all PCR. The imaging densitometer model GS-670 from Bio-Rad Laboratories (Mississauga, ON, Canada) along with Molecular Analyst v.1.2 software was used for quantitation of DNA bands following electrophoresis. The hybridization assays were performed using the Amerlite shaker/incubator from Amersham (Oakville, ON, Canada). Bioluminescence was measured using the MLX Microtiter Plate Luminometer from Dynex Technologies (Chantilly, VA).
Materials
Streptavidin was obtained from Sigma (St Louis, MO). The T7 RNA polymerase and NAP-5 columns were from Pharmacia (Montreal, PQ, Canada). The Wizard PCR Preps DNA purification system, the Wizard Plus Maxipreps DNA purification system and the plasmid pSP64 Poly(A) were from Promega Corporation (Madison, WI). The TNT T7 coupled wheatgerm extract system and the TNT T7 coupled rabbit reticulocyte lysate system are available from Promega. Terminal deoxynucleotidyl transferase, digoxigenin-11-2′-deoxyuridine 5′-triphosphate (Dig-dUTP) and blocking reagent (catalogue no. 1096 176) were from Boehringer Mannheim Biochemica (Laval, PQ, Canada). The plasmid pSVAEQN and aequorin (Aqualite aequorin, recombinant biotinylated) were obtained from Molecular Probes (Eugene, OR). The Pfu DNA polymerase, used in PCR, was from Stratagene (La Jolla, CA). All restriction enzymes used were purchased from New England Biolabs (Mississauga, ON, Canada) and were used according to the manufacturer's suggestions except where noted. The Qiaquick gel extraction kit from Qiagen (Mississauga, ON, Canada) was used for all purifications of DNA from agarose gel. Biotin-14-dATP and U-bottom, transparent polystyrene lock wells (Nunc Maxisorp) were from Life Technologies (Burlington, ON, Canada). Flat bottom, Microlite 2 Removawells were from Dynatech Laboratories (Chantilly, VA). Primers A 1 (5′-GCT CTA GAC TAA TAC GAC TCA CTA TAG GGA GAA TGG TCA AGC TTA CA-3′), containing a XbaI restriction site, the T7 promoter sequence and the first five codons of the apoaequorin coding sequence, and A 2 (5′-CGA GCT CCT TAG GGG ACA GCT CCA CC-3′), containing the last five codons of the apoaequorin coding sequence, the stop codon and a SacI restriction site, were synthesized by Biosynthesis Inc. (Lewisville, TX). Oligo 1 (5′-AATT CGC CAC ACA CAC TCC-3′, phosphorylated at the 5′-end) and Oligo 2 (5′-TGT GTG TGG CG-3′), used in preparation of the adapter, were also from Biosynthesis. Coelenterazine and anti-digoxigenin antibody labeled with aequorin was from Sealite Sciences (Norcross, GA). A stock solution of 2.5 mmol/l coelenterazine was prepared by dissolving the solid in 0.1 mol/l HCl in deoxygenated methanol (supplied by the manufacturer). The stock solution is stable for 6 months at -20°C. The working solution of coelenterazine was prepared immediately before use by diluting the stock in DEPC-treated water.
The target DNA was a 233 bp fragment produced by reverse transcription-PCR of the prostate-specific antigen mRNA, as described in detail elsewhere (15) . The concentration of target DNA was determined by scanning densitometry of photographic negatives taken from ethidium bromide stained agarose gels. Biotinylated target DNA was prepared using the same technique except that a 5′ biotinylated upstream primer was used for the PCR. The oligonucleotides used as probes in this work were complementary to the target regions bp 67-90 (P 1 ) and 214-233 (P 2 ).
The hybridization buffer consisted of 10 g/l blocking reagent, 60 mmol/l citrate and 0.6 mol/l NaCl, pH 7.0. The A-T annealing buffer contained 10 g/l blocking reagent, 90 mmol/l citrate, 0.9 mol/l NaCl, pH 7.0. The wash solution was made up of 50 mmol/l Tris, pH 7.4, 0.15 mol/l NaCl and 0.1% (v/v) Tween-20. The composition of the aequorin luminescencetriggering solution was 100 mmol/l Tris-HCl, pH 7.5, 100 mmol/l CaCl 2 .
Preparation of an expressible, apoaequorin-coding DNA fragment
The expressible DNA fragment encoding apoaequorin (Aeq DNA), containing the T7 RNA polymerase promoter upstream from the apoaequorin coding sequence, was obtained from the plasmid pSVAEQN by PCR using Pfu polymerase and oligonucleotides A 1 and A 2 as upstream and downstream primers, respectively. The resulting 613 bp product (Aeq DNA) was purified using the Wizard PCR Preps system. The DNA was quantitated as described above.
An expressible, apoaequorin-coding DNA fragment (Aeq[dA/dT]) consisting of a T7 promoter, an apoaequorin coding sequence and a downstream (dA/dT) 30 extension was prepared as follows. Purified Aeq DNA (from two PCR reactions) was digested with XbaI then purified using the Wizard PCR Preps system. The plasmid pSP64 Poly(A) (4 µg) was also digested with XbaI and then purified by ethanol precipitation (16) . Following quantitation, purified linearized pSP64 Poly(A) DNA was dephosphorylated and ligated to the digested Aeq DNA using a 1:4 molar ratio. The product was digested with SacI, electrophoresed and the 3619 bp band was excised and purified. After circularization, the resulting plasmid, named pSP64-AEQ, was used for transfection of competent JM109 cells (16) . The transformed cells were grown in LB broth containing 0.1 g/l ampicillin. The plasmid was isolated and purified using the Wizard Plus Maxipreps system. Subsequently, pSP64-AEQ was digested with XbaI and EcoRI simultaneously (reaction performed in 1× EcoRI buffer), electrophoresed and the 645 bp fragment (Aeq[dA/dT]), containing the T7 promoter, the apoaequorin coding sequence and the (dA/dT) 30 extension, was excised and purified.
Tailing of Aeq[dA/dT] DNA with dATP pSP64-AEQ was digested with EcoRI. An EcoRI adapter, containing an upstream 5′-overhang complementary to the EcoRI digestion product (Aeq[dA/dT]) and a downstream nonspecific 3′-overhang, was prepared by mixing equal volumes of 100 µmol/l solutions of Oligo 1 and Oligo 2, heating the resulting solution to 55°C for 10 min and gradually cooling to room temperature. The adapter was then ligated to pSP64-AEQ using a 4:1 molar ratio. The ethanol-precipitated product was digested with XbaI, electrophoresed and the 657 bp fragment was excised, purified and quantitated. The purified DNA (4.7 pmol) was enzymatically tailed using terminal deoxynucleotidyl transferase in the presence of a 100-fold molar excess of dATP (24 µmol/l in a 20 µl reaction). The reaction was terminated by the addition of 2 µl of 0.2 mol/l EDTA. The tailed DNA template (Aeq[dA/dT]-A x ) was used directly as a reporter molecule in hybridization assays without further purification.
Labeling of oligonucleotide probes
The oligonucleotide used as the capture probe in sandwich hybridization assays was enzymatically tailed with biotin-14-dATP as described above (under Tailing of Aeq[dA/dT] DNA) except that 100 pmol of the oligonucleotide was tailed with 50 µmol/l biotin-14-dATP and 0.5 mmol/l (total concentration) dNTPs, instead of dATP. The biotinylated probe was purified by gel filtration using a NAP-5 column. The oligonucleotide used as a detection probe in hybridization assays was enzymatically tailed as above with 0.5 mmol/l dTTP. Detection probe labeled with Dig-dUTP was prepared by tailing 100 pmol of the oligonucleotide with 50 µmol/l Dig-dUTP and 0.5 mmol/l dATP.
Hybridization assays based on in vitro expression of a DNA label encoding apoaequorin
Captured target assay configuration. U-bottomed wells were coated overnight, at room temperature, with 25 µl of 1.4 mg/l streptavidin in PBS. Prior to use the wells were washed three times with wash solution. A 25 µl aliquot of biotinylated target DNA (diluted in PBS containing 0.5 ml/l Tween-20) was pipetted into each well and allowed to bind for 30 min at room temperature with shaking. The wells were washed as above and then one strand of the target DNA was removed by incubating for 20 min with 25 µl 0.2 mol/l NaOH. The wells were washed and 25 µl of 1.75 nmol/l of dTTP-tailed probe P 1 , diluted in hybridization buffer, were added to each well and allowed to hybridize for 30 min at 42°C with shaking. The excess probe was removed by washing with wash solution containing 2 mmol/l EDTA and 25 µl of 0.125 nmol/l Aeq[dA/ dT]-A x DNA, diluted in A-T annealing buffer, were added to each well and then allowed to anneal for 10 min at room temperature. The wells were then washed five times with wash solution containing 2 mmol/l EDTA and twice with 50 mmol/l potassium acetate, 2 mmol/l EGTA. The Aeq[dA/dT] DNA bound to the hybrids was transcribed and translated in a cellfree one-step reaction by adding 25 µl of a wheatgerm TNT mixture supplemented with 8.3 µmol/l coelenterazine. Expression was allowed to proceed for 90 min at 30°C followed by the addition of 10 µl 0.25 mol/l DTT. The mixture was transferred to opaque flat-bottomed wells and 50 µl of the Ca 2+ -containing luminescence-triggering solution were added to each well and the light emission was integrated for 3 s.
Sandwich-type assay configuration.
A 25 µl aliquot of 3.5 nmol/l biotinylated probe P 2 , diluted in PBS containing 0.5 ml/l Tween-20, was pipetted into each streptavidin-coated well. Following a 30 min incubation (at room temperature with shaking), the wells were washed three times. A 20 µl aliquot of 0.625 nmol/l dTTP-tailed probe P 1 (diluted in hybridization buffer and preheated to 42°C) was pipetted into each well. The target DNA (diluted in 10 g/l blocking reagent) was denatured by heating at 95°C for 10 min and cooled on ice. Subsequently, 5 µl of the denatured target was added to each well and allowed to hybridize with the two probes for 1 h at 42°C. The wells were washed three times with wash solution containing 2 mmol/l EDTA and 25 µl of 0.125 nmol/l Aeq[dA/dT]-A x DNA, diluted in A-T annealing buffer, were added per well and then allowed to anneal to the immobilized detection probe for 10 min at room temperature. The wells were washed five times with wash solution containing 2 mmol/l EDTA and then twice with 50 mmol/l potassium acetate, 2 mmol/l EGTA. The Aeq[dA/dT] DNA was then expressed and the generated aequorin was measured as described under Captured target assay configuration.
Hybridization assay using the photoprotein aequorin as a label
Flat-bottomed microtiter wells were coated with streptavidin as described above for the U-bottomed ones, except that 50 µl of coating solution was used instead of 25 µl. The capture of biotinylated target DNA and removal of one strand were carried out as described under Captured target assay configuration, except that 50 µl volumes were used instead of 25 µl. Subsequently, 50 µl of 1.75 nmol/l Dig-tailed probe P 1 , diluted in hybridization buffer, were added and the probe was allowed to hybridize for 30 min at 42°C. The wells were washed three times with wash solution containing 2 mmol/l EDTA, followed by the addition of 50 µl of 10 µg/l aequorin-labeled antidigoxigenin antibody diluted in 10 g/l blocking reagent, 0.1 mol/l maleic acid, 0.15 mol/l NaCl, 2 mmol/l EGTA (pH 7.5). The immunoreaction was allowed to proceed for 30 min at room temperature and the excess antibody was removed by washing the wells with wash solution containing 2 mmol/l EDTA. To each well, 50 µl of the Ca 2+ -containing luminescence-triggering solution were added and the signal was integrated for 3 s.
Hybridization assay based on in vitro expression of a DNA label encoding firefly luciferase The 4.3 kb plasmid pLUCEXP (3, 17) , containing the T7 RNA polymerase promoter, the firefly luciferase coding sequence and a downstream (dA/dT) 30 extension, was linearized with iv BglI (17) and tailed enzymatically with dATP as described above for the apoaequorin DNA. The resultant DNA (Luc-A x ) was used as a label in the hybridization assay. The assay was carried out exactly as described under Captured target configuration except that 0.125 nmol/l Luc-A x DNA was used instead of the Aeq[dA/dT]-A x DNA during the A-T annealing step. After incubating for 10 min at room temperature, the wells were washed five times with wash solution containing 2 mmol/l EDTA and then twice with 50 mmol/l potassium acetate, 2 mmol/l EGTA. The bound Luc DNA was subjected to transcription/translation by adding 25 µl of the rabbit reticulocyte TNT mixture and incubating for 90 min at 30°C. The activity of generated luciferase was determined by mixing 2 µl of the reaction mixture and 60 µl of luciferase substrate buffer (18) and measuring the luminescence with a delay time of 2 s and an integration time of 30 s.
RESULTS AND DISCUSSION
An in vitro expressible DNA fragment (Aeq DNA), consisting of a T7 RNA polymerase promoter and a sequence encoding apoaequorin, was prepared as illustrated in Figure 1 and described above. The addition of a (dA/dT) 30 extension to Aeq DNA, downstream of the apoaequorin coding sequence, is also shown diagrammatically in Figure 1 . The primers A 1 and A 2 contained the sequences for XbaI and SacI restriction sites which were incorporated, through PCR, at the 5′-and 3′-end of the Aeq DNA, respectively. The plasmid pSP64 Poly(A) was used as the source of the (dA/dT) 30 sequence. The Aeq DNA was inserted between the XbaI and SacI sites of pSP64 Poly(A) to create the new plasmid pSP64-AEQ (Fig. 1) . Cleavage of pSP64-AEQ with XbaI and EcoRI produced the desired Aeq[dA/dT] DNA (645 bp) in which the (dA/dT) 30 sequence is positioned downstream of the apoaequorin gene. In order to be used as a label in hybridization assays, the Aeq[dA/dT] DNA was tailed enzymatically with dATP to produce Aeq[dA/dT]-A x . However, it has been reported that tailing of recessive 3′-ends (such as those produced by EcoRI digestion) by terminal deoxynucleotidyl transferase is inefficient (19) . In order to create a protruding 3′-end, we ligated a suitable adapter to the Aeq[dA/dT] DNA. The adapter had an upstream cohesive end with the EcoRI cleavage site of Aeq[dA/dT] DNA and a v downstream non-specific 3′-overhang (see Fig. 1 ). The resultant DNA was purified and tailed. The Aeq[dA/dT]-A x DNA was used directly in hybridization assays without further purification.
A highly sensitive hybridization assay, based on the in vitro expression of an apoaequorin-coding DNA label, presupposes that the aequorin produced can be measured readily in the transcription/translation mixture without prior purification. In order to investigate the possibility that components of the expression mixture interfere with aequorin measurement, we spiked a wheatgerm-based and a rabbit reticulocyte-based expression mixture (TNT T7 coupled; Promega) with recombinant aequorin (final concentration 55 pmol/l) and the luminescence was compared with a 55 pmol/l aequorin solution in 10 mmol/l Tris-HCl, pH 7.5, 10 mmol/l EGTA, 1 mol/l KCl, 10 mmol/l MgCl 2 , 1 g/l BSA, 1 g/l sodium azide. We found that the components of wheatgerm extract do not interfere with aequorin measurement. In contrast, the reticulocyte lysate caused a 40-fold decrease in the signal. This was attributed to the presence of hemoglobin in the reticulocyte mixture whose Soret band is close to the λ max of aequorin bioluminescence. As a consequence, light emitted from aequorin is absorbed by hemoglobin. Therefore, the wheatgerm-based expression mixture was used for all subsequent studies.
The time course of the formation of fully active aequorin, from coelenterazine and in vitro synthesized apoaequorin, was studied by subjecting 0.25 fmol of Aeq[dA/dT] DNA to a transcription/translation reaction for 90 min at 30°C in a total volume of 25 µl. At the end of this period aequorin formation was initiated by adding coelenterazine at a final concentration of 8 µmol/l. Aliquots were then removed at various time intervals (up to 4 h from the beginning of expression) and the luminescence of aequorin was measured immediately by adding the Ca 2+ -containing light-triggering solution. In Figure 2 (dashed line), the luminescence was plotted versus time (the 0 time corresponds to the start of the transcription/translation reaction). We observe that the luminescence increases with time and reaches a maximum after 60 min from the addition of coelenterazine. In another experiment, performed in parallel, coelenterazine was included in the expression mixture before the addition of Aeq[dA/dT] DNA. Aliquots of the reaction mixture were removed at various time intervals and the luminescence was measured immediately. The results are also presented in Figure 2 (solid line). A continuous increase in the luminescence was observed and a plateau was reached at 150 min. A significant finding is that the maximum luminescence values obtained were the same for the two experiments. Consequently, coelenterazine does not interfere with the transcription/translation reaction, thus permitting simultaneous apoaequorin synthesis and aequorin formation. In order to achieve a high yield of active aequorin without compromising the practicality of the proposed assays, we included coelenterazine in the expression mixture and allowed the reaction to proceed for 90 min only, at which time 81% of the maximum luminescence signal was obtained.
The effect of the concentration of coelenterazine on the formation of aequorin was studied by performing transcription/ translation of 28 amol Aeq[dA/dT] DNA for 90 min at 30°C with various concentrations of coelenterazine included in the expression mixture. At the end of this period the Ca 2+ -containing light-triggering solution was added and the luminescence was measured. The results are presented in Figure 3 . A continuous increase in the luminescence with coelenterazine concentration is observed and a maximum is reached at 8 µmol/l. The decrease in luminescence at higher coelenterazine concentrations might be due to the presence of an inhibitor in the coelenterazine solution (perhaps coelenteramide) (20) .
To assess the performance of Aeq DNA and Aeq[dA/dT] DNA as labels, various amounts of each DNA fragment were subjected to in vitro one-step transcription/translation (for 90 min at 30°C) using a wheatgerm-based expression mixture e25 Nucleic Acids Research, 1999, Vol. 27, No. 19 vi (total volume 25 µl) which contained 8.3 µmol/l coelenterazine. The aequorin produced was determined by adding the Ca 2+ -containing triggering solution and measuring the luminescence. In Figure 4 , the luminescence is plotted against the number of DNA molecules introduced into the expression mixture. It is observed that the luminescence is a linear function of the input Aeq DNA and Aeq[dA/dT] DNA. Moreover, the Aeq[dA/dT] DNA gives about 25 times higher expression yield than the Aeq DNA. As low as 5000 Aeq[dA/dT] DNA molecules can be detected with a signal:background ratio of 2.0 and the linearity extends up to 10 8 molecules (over four orders of magnitude). From the signals obtained at various DNA levels and an aequorin calibration curve, prepared by diluting commercially available recombinant aequorin (in 10 mmol/l Tris-HCl, pH 7.5, 10 mmol/l EGTA, 1 mol/l KCl, 10 mmol/l MgCl 2 , 1 g/l BSA, 1 g/l sodium azide), it was estimated that 6.5 molecules of aequorin were synthesized from each Aeq DNA and 156 aequorin molecules were generated from each Aeq[dA/dT] DNA molecule. Therefore, the Aeq[dA/dT] DNA was used as the label for development of the hybridization assays. It has been reported that the poly(A) tail enhances the translation efficiency in vivo by facilitating translation initiation and controlling mRNA stability (21) .
The relative positions of the oligonucleotide probes used in the hybridization assays are shown in Figure 5 (upper panel) . A schematic presentation of the various hybridization assay configurations studied is shown in the lower panel of Figure 5 . Configurations (a) and (b) were based on in vitro expression of the apoaequorin-encoding DNA (Aeq[dA/dT]). In the captured target configuration (a), biotinylated target DNA is first bound to streptavidin-coated wells. Then, one strand is removed by NaOH treatment and the other is hybridized with probe P 1 that contains a dT tail at the 3′-end (P 1 -T x ). The dT tail allows for subsequent binding of the Aeq[dA/dT]-A x DNA to the hybrids. Biotinylated target DNA may be prepared by PCR, using the appropriately biotinylated upstream primer (15) (as performed in the current study), when the target is rare or by ligation of a biotinylated adapter DNA to restriction-digested target DNA.
Previous studies have shown that aqueous solutions of coelenterazine exhibit a low level luminescence which has been attributed to the auto-oxidation of coelenterazine (22) . Our studies show that a 25 µl aliquot of wheatgerm-based expression mixture supplemented with 8.3 µmol/l coelenterazine (the solution used in the hybridization assays) and containing no apoaequorin-coding DNA gave a typical luminescence value of 2.34 RLU with the instrument settings for aequorin measurement. In the absence of coelenterazine, the luminescence was only 0.35. This luminescence was not dependent on addition of the Ca 2+ -containing triggering solution. Furthermore, it was found that this luminescence was gradually decreased when increasing concentrations of DTT were added to the expression mixture. When DTT was added to the expression mixture to a final concentration of 71 mmol/l the luminescence dropped to less than 0.4. This addition of DTT did not interfere with the subsequent aequorin measurement.
The effect of the concentration of apoaequorin-coding DNA was studied by preparing various dilutions of Aeq[dA/dT]-A x in A-T annealing buffer and using them in the hybridization assay of 50 amol of target DNA. In Figure 6 the luminescence and the signal:background ratio are plotted versus the Aeq[dA/ dT]-A x concentration. The background is defined as the luminescence observed when no target DNA is present in the well and is mainly due to non-specific binding of the detection probe and the Aeq[dA/dT]-A x DNA to the solid phase. We observe that the luminescence increases with Aeq[dA/dT]-A x concentration and a plateau is reached at 0.375 nmol/l. However, a peak in the signal:background ratio occurs at 0.125 nmol/l. At higher concentrations the non-specific binding of Aeq[dA/dT]-A x DNA increases and the signal:background ratio drops. Figure 7 shows the effect of concentration of the detection probe P 1 -T x on the luminescence and the signal:background ratio of the hybridization assay. The luminescence reaches a maximum at 2 nmol/l probe and then remains constant, whereas the signal:background ratio decreases because of the increased non-specific binding of the probe at high concentrations. A final probe concentration of 1.75 nmol/l was chosen as the optimum for the captured target assay configuration.
In order to assess the performance of the optimized captured target hybridization assay (Fig. 5a ), various dilutions of target DNA were analyzed and the luminescence (corrected for the background) was plotted as a function of the amount of DNA. The results are presented in Figure 8 . The assay is linear in the range 0.5-7812 amol of target DNA, a range spanning over four orders of magnitude. The signal:background ratio at the level of 0.5 amol is 1.9.
In the sandwich-type hybridization assay (Fig. 5b) , the target DNA (unlabeled) hybridizes simultaneously with two probes, i.e. probe P 2 , which is immobilized on the well through biotinstreptavidin interaction, and probe P 1 -T x . The Aeq[dA/dT]-A x DNA is bound to the hybrids followed by in vitro expression. Optimization studies similar to those outlined above for the captured target assay configuration, were carried out and it was found that the highest signal:background ratios were obtained using 3.5 nmol/l probe P 2 , 0.625 nmol/l P 1 -T x and 0.125 nmol/l Aeq[dA/dT]-A x DNA. Data pertaining to the sensitivity and linearity of the sandwich-type hybridization assay are presented in Figure 8 . The linearity extends from 0.25 to 1562 amol of target DNA. The signal:background ratio at the level of 0.25 amol is 1.4.
The reproducibility of the proposed sandwich-type hybridization assay was assessed by analyzing samples containing 5, 50 and 500 amol of target DNA. The CVs were 10.9, 9.1 and 4.2%, respectively (n = 4). The captured target hybridization assay gave CVs of 6.0, 12.7 and 11.5% for 5, 500 and 2500 amols of target DNA, respectively (n = 4).
The photoprotein aequorin has been used as a reporter molecule in hybridization assays and immunoassays (10) (11) (12) (13) (14) . In order to compare the sensitivity of the proposed method, which uses a DNA label encoding apoaequorin, with the method that employs the protein aequorin as a label, we performed a captured target hybridization assay using the same detection probe (P 1 ) tailed with Dig-dUTP at the 3′-end. The hybrids were determined by reacting with an anti-digoxigenin antibody labeled with aequorin (see Fig. 5c ). The results (luminescence versus the amount of target DNA) are presented in Figure 8 . The aequorin-based assay can detect 25 amol of target DNA per well with a signal:background ratio of 1.6. The dramatic improvement in sensitivity observed when a DNA encoding viii apoaequorin is used as a label instead of aequorin, is due to the amplification introduced by the in vitro expression of apoaequorin DNA into several active aequorin molecules.
The proposed system was compared with a previously described hybridization assay (17) , which was based on a DNA label encoding firefly luciferase. A captured target hybridization assay was performed [see Fig. 5 , (d)] using probe P 1 with a dT tail at the 3′-end (P 1 -T x ). The hybrids were reacted with Luc-A x DNA. The bound Luc DNA was expressed and the activity of generated luciferase was measured. The luminescence was plotted against the amount of target DNA (see Fig.  8 ). It is observed that the luciferase-based assay can detect 20.5 amol of target DNA with a signal:background ratio of 1.9. Thus, there is a 40-fold improvement in sensitivity using the DNA encoding apoaequorin as label.
Sensitivity is a main focus of research in the area of DNA analysis. The detection/determination of specific DNA or RNA sequences in small biological samples or in samples containing low copy numbers of the sequence of interest is a common and challenging analytical problem. Examples include the quantification of viral or bacterial nucleic acids present in minute amounts in human body fluids and other clinical and environmental samples. Also, the diagnosis and monitoring of neoplastic disorders is frequently based on the analysis of very low concentrations of DNA/RNA sequences which are specific and characteristic of malignant cells in the presence of a vast excess of nucleic acids from normal cells. One approach to these problems involves exponential amplification of the target nucleic acid sequence (e.g. by PCR) to levels that are several orders of magnitude higher than that in the starting material. Although target amplification techniques provide the required sensitivity, the potential contamination of the samples by amplified sequences is a serious drawback. Moreover, quantification of the initial target DNA is difficult since it requires the use of internal standards to compensate for fluctuations in the amplification efficiency. In contrast, signal amplification methods provide sensitivity through the high detectability of the reporter molecule (label) while the amount of target nucleic acid remains constant, thus eliminating the above drawbacks. The proposed system offers a significant improvement in sensitivity and is amenable to automation since the assays are performed in microtiter wells and blotting procedures and membrane hybridization are avoided.
